Matthew Michelson

Matthew Michelson is the current CEO of Evid Science and was previously the President of Genesis AI at Genesis Research. Matthew has also been an advisor for Cytenna, a part-time faculty member at the University of Southern California, and the Director of Data Science and Chief Scientist at InferLink Corporation.

Matthew Michelson has a wealth of experience in AI and tech-enabled solutions. Matthew has focused their career on providing services and technology to the pharmaceutical industry. Their experience in market access, HEOR, R&D, and medical affairs functions has made him a well-rounded leader in the industry.

Under Michelson's guidance, Genesis Research was acquired by GHO Capital in November of 2021. Prior to this, they served as the Chief Scientist at InferLink Corporation from February 2013 to May 2015. Matthew then took on the role of Director of Data Science at Retention Science from June 2015 to December 2015 before returning to InferLink Corporation as their Chief Scientist from December 2015 to December 2020.

Most recently, Michelson has been teaching the graduate level course: Foundations and Applications of Data Mining at the University of Southern California while also serving as an advisor for Cytenna. In April of 2022, they became the CEO of Evid Science.

Matthew Michelson attended The Johns Hopkins University for their undergraduate degree in computer science. Matthew then attended the University of Southern California for their masters and Ph.D. in computer science.

Tiffany Chow - Scientific Client Liaison, Brian Amanatullah - VP, Engineering, and Noah Goldberg - VP Head of Business Development report to Matthew Michelson.